Press Releases
Calls for allowing Medicare to negotiate for lower prices and for increasing drug-price transparency, denounces Big Pharma’s role in politics
WASHINGTON -- U.S. Rep. Elissa Slotkin (MI-08) yesterday delivered forceful testimony before the House Ways and Means Committee demanding Congress and the Ways and Means committee take action to pass legislation that lowers the price of prescription drugs.
Group of House lawmakers work together to advance bipartisan legislation
WASHINGTON -- U.S. Rep. Elissa Slotkin (MI-08) announced today that she has joined the bipartisan Problem Solvers Caucus. The group’s membership is evenly split between Democrats and Republicans, who collaborate on practical, pragmatic solutions to improve people’s lives, providing an important vehicle in the House of Representatives to advance bipartisan legislation.
Slotkin has launched four constituent-led advisory boards on issues related to veterans, seniors, healthcare, and sexual assault
LANSING –– U.S. Rep. Elissa Slotkin (MI-08) yesterday convened a joint meeting of her Healthcare and Seniors district advisory boards, as well as the inaugural meeting of her Title IX district advisory board. Slotkin sought input from board members on upcoming bills she is introducing this month to help lower the price of prescription drugs and prevent sexual assault.
MACKINAC, MI -- U.S. Rep. Elissa Slotkin (MI-08) released the following statement in response to Special Counsel Robert Mueller’s public statement on the conclusion of his report:
PAID AD Act closes loopholes that allow foreign entities to legally purchase campaign ads on social media, TV
WASHINGTON — U.S. Rep. Elissa Slotkin (MI-08) on Thursday introduced bipartisan legislation with Rep. Elise Stefanik (NY-21) that would close loopholes that currently allow foreign interests and foreign governments to legally purchase digital and TV ads for the purpose of influencing U.S. elections.
SECURE Act passed the House, 417-3
WASHINGTON -- U.S. Rep. Elissa Slotkin (MI-08) today voted in favor of H.R.
Bill takes sweeping action to drive down costs, reverse Administration’s actions to chip away at healthcare access
WASHINGTON -- U.S. Rep. Elissa Slotkin (MI-08) today voted in favor of a major piece of legislation to lower the cost of healthcare and prescription drugs.
EPA currently does not require drinking water to be tested for PFAS
WASHINGTON -- U.S. Rep. Elissa Slotkin (MI-08) today introduced the PFAS Monitoring Act, a bill that would require public water systems to test for at least 30 per- and polyfluoroalkyl substances (PFAS) chemicals, and would require the full range of PFAS chemicals to be tested after two years. Right now, the U.S.